| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Penumbra Inc (NYSE: PEN)
PEN Technical Analysis
5
| As on 9th Jun 2023 PEN STOCK Price closed @ 323.09 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 184.30 & Strong Buy for SHORT-TERM with Stoploss of 235.42 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PENSTOCK Price
| Open | 315.80 | Change | Price | % |
| High | 325.02 | 1 Day | 8.37 | 2.66 |
| Low | 315.80 | 1 Week | 15.75 | 5.12 |
| Close | 323.09 | 1 Month | 39.93 | 14.10 |
| Volume | 199173 | 1 Year | 63.43 | 24.43 |
| 52 Week High 322.37 | 52 Week Low 116.09 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| PEN Daily Charts |
PEN Intraday Charts |
Whats New @ Bazaartrend |
PEN Free Analysis |
|
|
PEN Important Levels Intraday
| RESISTANCE | 340.86 |
| RESISTANCE | 335.16 |
| RESISTANCE | 331.64 |
| RESISTANCE | 328.11 |
| SUPPORT | 318.07 |
| SUPPORT | 314.54 |
| SUPPORT | 311.02 |
| SUPPORT | 305.32 |
PEN Forecast May 2024
| 4th UP Forecast | 468.83 |
| 3rd UP Forecast | 422.09 |
| 2nd UP Forecast | 393.2 |
| 1st UP Forecast | 364.31 |
| 1st DOWN Forecast | 281.87 |
| 2nd DOWN Forecast | 252.98 |
| 3rd DOWN Forecast | 224.09 |
| 4th DOWN Forecast | 177.35 |
PEN Weekly Forecast
| 4th UP Forecast | 364.62 |
| 3rd UP Forecast | 351.30 |
| 2nd UP Forecast | 343.07 |
| 1st UP Forecast | 334.83 |
| 1st DOWN Forecast | 311.35 |
| 2nd DOWN Forecast | 303.11 |
| 3rd DOWN Forecast | 294.88 |
| 4th DOWN Forecast | 281.56 |
PEN Forecast2024
| 4th UP Forecast | 731.96 |
| 3rd UP Forecast | 600.83 |
| 2nd UP Forecast | 519.78 |
| 1st UP Forecast | 438.73 |
| 1st DOWN Forecast | 207.45 |
| 2nd DOWN Forecast | 126.4 |
| 3rd DOWN Forecast | 45.35 |
| 4th DOWN Forecast | -85.78 |
Penumbra Inc ( NYSE USA Symbol : PEN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PEN Business Profile
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; immersive virtual reality and display system that displays and tracks upper-extremity rehabilitation exercises under the REAL Immersive System brand name; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand name, as well as a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and POD Packing Coil brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California. Address: One Penumbra Place, Alameda, CA, United States, 94502
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service